Corneal Thickness Changes in Patient Undergoing Dry Eye Managment
NCT04970329
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
96
Enrollment
OTHER
Sponsor class
Conditions
Dry Eye Disease
Interventions
DRUG:
Polyethylene Glycol 400 0.4%-Propylene Glycol 0.3%. and Dextran 0.1%Hypromellose 0.3%,
Sponsor
University of Faisalabad